Detailed studies of past epidemics show a repeating pattern: Infectious diseases more easily take hold in groups with pre-existing illnesses and who must live in crowded conditions. A similar trend is evident with COVID-19 devastating many minority communities, as recent data revealed.
Outbreaks and Epidemics
With a vaccine for the novel coronavirus still likely a year or more away, the first weapon against the virus could be one of the drugs now in clinical trials with COVID-19 patients.
Controversy surrounds the race to find a medical solution to COVID-19.
Mass vaccination campaigns against a host of diseases are already grinding to a halt in many countries.
Volunteer healthcare workers and underpaid nurses are keeping the virus at bay, for now.
The head of the World Health Organization today gave an impassioned but indirect rejoinder to recent comments from U.S. President Donald Trump criticizing WHO’s handling of the coronavirus pandemic.
Social scientists are examining how the coronavirus pandemic is affecting everything from people’s behavior to the economy.
Many people will likely deal with lingering effects of the coronavirus—and of the emergency treatments that allowed them to survive it.
Leaders at the European Research Council have hit back at its former president, who caused an uproar yesterday by resigning barely 3 months into the job.
Columbia Graduate School of Journalism student TuAnh Dam speaks to an ER doctor about her battle against COVID-19.
As the COVID-19 pandemic sweeps into South Africa, the country's experience with handling tuberculosis (TB) and HIV could give it an advantage. But those infections could also worsen the pandemic’s impact.
A trial was designed in which health care workers in Asia, Africa, and Europe will receive two old drugs used against malaria.